FIELD: medicine.
SUBSTANCE: central action dopamine agonist is administered. The administration is carried out so as to provide a peak of the dopamine agonist level in the plasma in a time interval between 4.00 and 12.00 pm.
EFFECT: effective treatment of the metabolic syndrome and associated nonmetabolic disorders due to normalization of the circadian rhythm of dopaminergic activity.
12 cl, 12 dwg, 11 ex
Authors
Dates
2017-07-03—Published
2012-12-14—Filed